These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11096359)
21. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. Nakagawa H; Yamamoto D; Kiyozuka Y; Tsuta K; Uemura Y; Hioki K; Tsutsui Y; Tsubura A J Cancer Res Clin Oncol; 2000 Aug; 126(8):448-54. PubMed ID: 10961387 [TBL] [Abstract][Full Text] [Related]
22. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268 [TBL] [Abstract][Full Text] [Related]
23. PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells. Roberts JL; Booth L; Conley A; Cruickshanks N; Malkin M; Kukreja RC; Grant S; Poklepovic A; Dent P Cancer Biol Ther; 2014 Jun; 15(6):758-67. PubMed ID: 24651037 [TBL] [Abstract][Full Text] [Related]
24. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy. Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097 [TBL] [Abstract][Full Text] [Related]
25. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs. Patties I; Kortmann RD; Menzel F; Glasow A J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342 [TBL] [Abstract][Full Text] [Related]
26. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503 [TBL] [Abstract][Full Text] [Related]
27. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells. Li W; Weber G Oncol Res; 1998; 10(3):117-22. PubMed ID: 9700722 [TBL] [Abstract][Full Text] [Related]
28. Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). Spiller SE; Ditzler SH; Pullar BJ; Olson JM J Neurooncol; 2008 Apr; 87(2):133-41. PubMed ID: 18060600 [TBL] [Abstract][Full Text] [Related]
29. Vincristine and lomustine induce apoptosis and p21(WAF1) up-regulation in medulloblastoma and normal human epithelial and fibroblast cells. Shinwari Z; Manogaran PS; Alrokayan SA; Al-Hussein KA; Aboussekhra A J Neurooncol; 2008 Apr; 87(2):123-32. PubMed ID: 18058069 [TBL] [Abstract][Full Text] [Related]
30. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. Wei J; Ma L; Li C; Pierson CR; Finlay JL; Lin J Curr Cancer Drug Targets; 2019; 19(7):571-582. PubMed ID: 30332965 [TBL] [Abstract][Full Text] [Related]
31. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Andrade AF; Borges KS; Suazo VK; Geron L; CorrĂȘa CA; Castro-Gamero AM; de Vasconcelos EJ; de Oliveira RS; Neder L; Yunes JA; Dos Santos Aguiar S; Scrideli CA; Tone LG Invest New Drugs; 2017 Feb; 35(1):26-36. PubMed ID: 27785591 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems. Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734 [TBL] [Abstract][Full Text] [Related]
33. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
34. Response of medulloblastoma cells to vincristine and lomustine: role of TRKC, CTNNB1 and STK15. Shinwari Z; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; El-Kum N; Aboussekhra A Anticancer Res; 2011 May; 31(5):1721-33. PubMed ID: 21617231 [TBL] [Abstract][Full Text] [Related]
35. Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Tamura S; Bito T; Ichihashi M; Ueda M Pigment Cell Res; 2003 Oct; 16(5):470-6. PubMed ID: 12950722 [TBL] [Abstract][Full Text] [Related]
36. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R; Tanabe K; Inoue H; Toge T Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567 [TBL] [Abstract][Full Text] [Related]
37. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779 [TBL] [Abstract][Full Text] [Related]
38. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167 [TBL] [Abstract][Full Text] [Related]
39. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289 [TBL] [Abstract][Full Text] [Related]
40. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. von Bueren AO; von Hoff K; Benesch M; Rutkowski S Klin Padiatr; 2009; 221(6):396-7. PubMed ID: 19890797 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]